William B. Hannah

MedicineAgricultural and Biological SciencesBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial”.

Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial

UNC Libraries(2020)10.17615/fzyc-s786

N/A

0DataRank · unranked

0 citations

Tong Gui, Scott McPhee, Carmen J. Booth, Junjiang Sun, Tal Kafri +11 more

Screening data from 19 patients with late‐onset Pompe disease for a phase I clinical trial of AAV8 vector‐mediated gene therapy

JIMD Reports(2023)10.1002/jmd2.12391

N/A

0DataRank · unranked

2 citations

Laura E. Case, Edward C. Smith, Crista Walters, Deeksha Bali, Priya S. Kishnani +2 more